EAACI Congress 2024

Back
31 May - 03 June 2024 Valencia, Spain

TPS50 - ENT 2

Saturday 01 Jun, 12:00 PM - 13:00 PM Valencia, Spain
Poster Zone Thematic Poster Session
Chacterisation of long-term nasal decongestant users and structured withdrawal of the nasal decongestant
Demographic Features Of Allergic Rhinitis Patients and Effect of Nasal Corticosteroid Treatment
Determinants of Adherence of Biologic Therapies in Chronic Rhinosinusitis
Diagnosis and Treatment of Allergies at ENT Department of General Hospital of Nafplio, Greece
Exhaled nitric oxide as a predictor of nasal polyp recurrence
Inotodiol attenuates mucosal inflammation in a mouse model of eosinophilic chronic rhinosinusitis
PERSISTENT REDUCTION OF TOTAL SERUM IgE IN CRSwNP AFTER ESS WITH SHORT COURSE DUPILUMAB
Role of non-pharmacological interventions in cypress pollen allergic rhinitis
The Role of Rho GTPase Signaling on Epithelial-Mesenchymal Transition and Inflammation of Chronic Rhinosinusitis with Nasal Polyp
The association between specific IgE levels and severity of allergic rhinitis, risk of allergic comorbidities
Use of nasal irrigation as add on therapy to non responders to pharmacotherapy in chronic adenoiditis

Chairs

Speakers